Federal actions in 2025-2026 aim to combat record drug shortages through API stockpiling, AI forecasting, and second-source manufacturing-but gaps in funding, reporting, and economic incentives still leave patients at risk.
Federal actions in 2025-2026 aim to combat record drug shortages through API stockpiling, AI forecasting, and second-source manufacturing-but gaps in funding, reporting, and economic incentives still leave patients at risk.